| 常用名 | Patritumab | CAS号 | 1262787-83-6 |
|---|---|---|---|
| 价格 | ¥需询单/100ug ¥需询单/500ug | 纯度 | 95.0% |
| 备货期 | 需询单 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and Akt. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors[1]. 物理化学性质: CAS号:1262787-83-6 常用中文名:Patritumab 常用英文名:Patritumab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |